FOLFOX4方案化疗对结直肠癌患者免疫细胞数的影响 |
| |
引用本文: | 王志超,黄延年.FOLFOX4方案化疗对结直肠癌患者免疫细胞数的影响[J].中国当代医药,2010,17(21):33-34. |
| |
作者姓名: | 王志超 黄延年 |
| |
作者单位: | 1. 中山大学附属博济医院肿瘤科,广东,广州,511300 2. 中山大学附属博济医院普外科,广东,广州,511300 |
| |
摘 要: | 目的:探讨FOLFOX4方案治疗结直肠癌对患者免疫细胞数的影响及意义。方法:检测47例结直肠癌患者化疗前和化疗后的第1、4、7天T细胞亚群、NK细胞数目变化以及淋巴细胞的凋亡情况,并与正常对照组进行对比。结果:患者化疗前CD3、CD4、CD16+56+细胞及CD4/CD8的比值较正常对照组低(P〈0.05),CD8水平无统计学差异。化疗结束后的1、4、7d,CD3、CD4、CD8、NK细胞的水平较化疗前降低,化疗后第4天下降到最低值,化疗后第7天各指标均有所回升,整个过程中CD4/CD8无显著变化。结论:FOLFOX4方案较为安全有效,但年老体弱者使用时需要注意检测和保护。
|
关 键 词: | FOLFOX4 结直肠癌 免疫细胞 |
FOLFOX4 regimen for patients with colorectal cancer the number of immune cells |
| |
Authors: | WANG Zhichao HUANG Yannian |
| |
Institution: | 1.Oncology Department,Boji Hospital Affiliated of SunYat-Sen University in Guangdong Province,Guangzhou 510300, China;2.General Surgery Department,Boji Hospital Affiliated of SunYat-Sen University in Guangdong Province,Guangzhou 510300,China) |
| |
Abstract: | Objective:To explore the alteration of the immune cell numbers of colorectal cancer patients that received FOLFOX4 chemotherapy.Methods:Blood samples form 47 colorectal patients who received FOLFOX4 chemotherapy and 47 health people as blank control,flow cytometry was applied to detect immune cell numbers and apoptotic rate. Results:Before the chemotherapy,the number of CD3,CD4,CD16+56+ cells and CD4/CD8 ratio were lower than the normal level (P 0.05),but there were no significant differences in CD8 cells.Slightly fall of T lymphocytes subsets and NK cell were found in patients after chemotherapy.On the 4th day it was the minimum value,on the 7th day all the value increased.The rate of CD4/CD8 remains unchanged in the whole process.Conclusion:FOLFOX4 chemotherapy is safe and useful,but to the old and sick,they should be carefully detected and protected during the chemotherapy. |
| |
Keywords: | FOLFOX4 |
本文献已被 维普 万方数据 等数据库收录! |
|